Author: Colavita, Francesca; Lapa, Daniele; Carletti, Fabrizio; Lalle, Eleonora; Messina, Francesco; Rueca, Martina; Matusali, Giulia; Meschi, Silvia; Bordi, Licia; Marsella, Patrizia; Nicastri, Emanuele; Marchioni, Luisa; Mariano, Andrea; Scorzolini, Laura; Ascoli Bartoli, Tommaso; Di Caro, Antonino; Ippolito, Giuseppe; Capobianchi, Maria Rosaria; Castilletti, Concetta
Title: Virological characterization of the first two COVID-19 patients diagnosed in Italy: phylogenetic analysis, virus shedding profile from different body sites and antibody response kinetics Cord-id: 5qfhyate Document date: 2020_9_2
ID: 5qfhyate
Snippet: BACKGROUND: The pathogenesis of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection remains unclear. We report the detection of viral RNA from different anatomical districts and the antibody profile in the first two COVID-19 cases diagnosed in Italy METHODS: We tested for SARS-CoV-2 RNA clinical samples, either respiratory and non-respiratory (i.e. saliva, serum, urine, vomit, rectal, ocular, cutaneous, and cervico-vaginal swabs), longitudinally collected from both patient
Document: BACKGROUND: The pathogenesis of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection remains unclear. We report the detection of viral RNA from different anatomical districts and the antibody profile in the first two COVID-19 cases diagnosed in Italy METHODS: We tested for SARS-CoV-2 RNA clinical samples, either respiratory and non-respiratory (i.e. saliva, serum, urine, vomit, rectal, ocular, cutaneous, and cervico-vaginal swabs), longitudinally collected from both patients throughout the hospitalization. Serological analysis was carried out on serial serum samples to evaluate IgM, IgA, IgG and neutralizing antibodies levels RESULTS: SARS-CoV-2 RNA was detected since the early phase of illness lasting over two weeks in both upper and lower respiratory tract samples. Virus isolate was obtained from acute respiratory sample, while no infectious virus was rescued from late respiratory samples with low viral RNA load, collected when serum antibodies had been developed. Several other specimens resulted positive including saliva, vomit, rectal, cutaneous, cervico-vaginal, and ocular swabs. Specific IgM, IgA and IgG were detected within the first week since diagnosis, with IgG appearing earlier and at higher titres. Neutralizing antibodies developed during the second week, reaching high titres 32 days since diagnosis CONCLUSIONS: Our longitudinally analysis showed that SARS-CoV-2 RNA can be detected in different body samples which may be associated with broad tropism and different spectra of clinical manifestations and modes of transmission. Profiling antibody response and neutralizing activity can assist laboratory diagnosis and surveillance actions
Search related documents:
Co phrase search for related documents- accession number and acute respiratory syndrome: 1, 2, 3
- accession number and live virus: 1
- accession number and load sample: 1
- acute respiratory syndrome and admission patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- acute respiratory syndrome and live virus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72
- acute respiratory syndrome and load sample: 1, 2, 3, 4, 5, 6, 7, 8
- acute respiratory syndrome and long duration: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27
- admission patient and long duration: 1
Co phrase search for related documents, hyperlinks ordered by date